Why cheaper alternatives to weight-loss drugs like Wegovy, Zepbound will be tougher to get
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
Zepbound copycats remain online despite FDA ban
Copycat versions of Eli Lilly's diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They're ...
Some People Are ‘Microdosing’ Ozempic—and Doctors Are Wary of the New Weight Loss Trend
More and more people are microdosing Ozempic, a popular weight loss drug, due to high costs and uncomfortable side effects.
BioSpace13d
GLP-1 Side Effects Only One Factor Driving Patient Discontinuation Rates
While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...
Verywell Health on MSN1d
Is 'Microdosing' Ozempic Safe?
Fact checked by Nick Blackmer “Microdosing” GLP-1 drugs like Ozempic is gaining attention on social media, but doctors say it ...
Mounjaro Launched in India: Price To Side-Effects, All You Need To Know About Ozempic-Like Weight Loss Drug
Eli Lillys famous weight loss drug will now be sold in India after the drug maker received approval from CDSCO. What are its ...
Morningstar4d
Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly’s Injectable Zepbound(R)
during the Study DehydraTECH-tirzepatide also evidenced reduced side effects, while achieving comparable concluding glycemic performance indicators. The injected Zepbound® produced a total of 38 ...
Lexaria Bioscience announces PK results on DehydraTech-Tirzepatide oral capsules
Lexaria Bioscience (LEXX) announced pharmacokinetic results from Human Study #3 or GLP-1-H24-3, comparing an oral version of ...
Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly’s Injectable Zepbound(R)
Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.